Abstract
Endothelin-1 (ET-1), a 21 amino acid peptide originally purified from conditioned medium of cultures of porcine aortic endothelial cells, is recognized as a product of many other cells as well. It is now known that there are three endothelin genes in the human genome (ET-1, ET-2, and ET-3). ET-1 and ET-2 are both strong vasoconstrictors, whereas ET-3 is a potentially weaker vasoconstrictor than the other two isoforms. Besides being the most potent vasoconstrictor yet known, ET-1 also acts as a mitogen on the vascular smooth muscle, and, thus, it may play a role in the development of vascular diseases. It is well known that accelerated angiopathy is a major complication in diabetes mellitus. As generalized endothelial cell damage is thought to occur in diabetic patients, ET-1, being released from the damaged endothelial cells, is able to make contact with the underlying vascular smooth muscle cells and thus could be one important cause of diabetic angiopathy. This article summarizes the reported literature of the role of ET-1 in the development of diabetic complications, with particular focus on the possible role of Et-1 in mediating the effects of angiotensin-converting enzyme inhibitors.
Similar content being viewed by others
References
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., and Mitsui, Y. (1988). Nature 332, 411–415.
Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., and Masaki, T. (1989). Proc. Natl. Acad. Sci. USA 86, 2863–2867.
Takahashi, M., Matsushita, Y., Ijima, Y., and Tanzawa, K. (1993). J. Biol. Chem. 268, 21,394–21,398.
Emoto, N. and Yanagisawa, M. (1995). J. Biol. Chem. 270, 15,262–15,268.
Shimada, K., Takahashi, M., Ikeda, M., and Tanzawa, K. (1995). FEBS Lett. 371, 140–144.
Valdenaire, O., Rohrbacher, E., and Mattei, M. G. (1995). J. Biol. Chem. 270, 29,794–29,798.
Schweizer, A., Valdenaire, O., Nelbock, P., et al. (1997). Biochem. chem. J. 328, 871–877.
Valdenaire, O., Lepailleur-Enouf, D., Egidy, G., et al. (1999). Eur. J. Biochem. 264, 341–349.
Masaki, T. (1993). Endocr. Rev. 14, 256–268.
Takahashi, K., Jones, P. M., Kanse, S. M, et al. (1990). Gastroenterology 99, 1660–1667.
Takahashi, K., Ghatei, M. A., Jones, P. M., et al. (1991). J. Clin. Endocrinol. Metab. 72, 693–699.
Takahashi, K., Ghatei, M. A., Jones, P. M., et al. (1991). J. Cardiovasc. Pharmacol. 17(Suppl. 7), S101-S103.
Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. (1990). Nature 348, 730–732.
Sakurai, T., Yanagisawa, M., Takuwa, Y., et al. (1990). Nature 348, 732–735.
Karne, S., Jayawickreme, C. K., and Lerner, M. R. (1993). J. Biol. Chem. 268, 19,126–19,133.
Moreland, S., McMullen, D. M., Delaney, C. L., Lee, V. G., and Hunt, J. T. (1992). Biochem. Biophys. Res. Commun. 184, 100–106.
Iwasaki, S., Homma, T., Matsuda, Y., and Kon, V. (1995). J. Biol. Chem. 270, 6997–7003.
Lam, H. C., Lee, J. K., and Lai, K. H. (2000). Endocrine 12, 77–80.
McMillen, M. A. and Sumpio, B. E. (1995). J. Am. Coll. surg. 180, 621–637.
McMillan, D. E. (1984). Microcirc. Endothel. Lymphat. 1, 3–24.
Rubanyi, G. M. and Botelho, L. H. (1991). FASEB J. 5, 2713–2720.
Nugent, A. G., McGurk, C., Hayes, J. R., and Johnstone, C. D. (1996). Diabetes 45, 105–107.
Sármán, B., Tóth, M., and Somogyi, A. (1998). Diabetes Metab. Rev. 14, 171–175.
Rohner, E. M. (1993). BMJ 307, 1195–1199.
Riva, C. E. and Loebl, M. (1977). Invest. Ophthalmol. 16, 586–592.
Chakravarthy, U. and Archer, D. B. (1992). Br. J. Ophthalmol. 76, 107, 108.
Ye, X., Laties, A. M., and Stone, R. A. (1990). Invest. Ophthalmol. 31, 1731–1737.
Cogan, D. G., Toussaint, D., and Kuwabara, T. (1961). Arch. Ophthalmol. 63, 366–368.
Herman, I. M. and D'Amore, P. A. (1985). J. Cell Biol. 101, 43–52.
Takahashi, K., Brooks, R. A., Kanse, S. M., Ghatei, M. A., Kohner, E. M., and Bloom, S. R. (1989). Diabetes 38, 1200–1202.
Nyborg, N. C. B., Pieto, D., Benedito, S., and Nielsen, P. J. (1991). Invest. Ophthalmol. Vis. Sci. 32, 27–31.
Chakravarthy, U., Gardiner, T. A., Anderson, P., Archer, D. B., and Trimble, E. R. (1992). Microvasc. Res. 43, 241–254.
Ogata, M., Naruse, M., Iwasaki, N., et al. (1998). J. Cardiovasc. Pharmacol. 31(Suppl. 1), S378,S379.
Temple, R. C., Carrington, C. A., Luzio, S. D., Owens, D. R., Schneider, A. E., and Sobey, W. J. (1989). Lancet 1, 293–295.
Hattori, Y., Kasai, K., Nakamura, T., Emoto, T., and Shimoda, S. (1991). Metabolism 40, 165–169.
Ferri, C. and De-Mattia, G. (1995). Metabolism 44, 689, 690.
Metsärinne, K., Saijonomaa, O., Yki-Järvinen, H., and Fyhrquist, F. (1994). Metabolism 43, 878–882.
Yamauchi, T., Ohnaka, K., Takayanagi, R., Umeda, F., and Nawata, H. (1990). FEBS Lett. 267, 16–18.
Wolpert, H. A., Steen, S. N., Istfan, N. W., and Simonson, D. C. (1993). Metabolism 42, 1027–1030.
Ferri, C., Carlomagno, A., Coassin, S., Baldoncini, R., and Cassone-Faldetta, M. R. (1995). Diabetes Care 18, 226–233.
Ferri, C., Laurenti, O., Bellini, C., et al. (1995). Am. J. Hypertens. 8, 40–71.
Frank, H. J. L., Levin, E. R., Pedram, A. (1993). Endocrinology 133, 1092–1097.
Takahashi, K., Suda, K., Lam, H. C., Ghatei, M. A., and Bloom, S. R. (1991). J. Endocrinol. 130, 123–127.
De la Rubia, G., Oliver, F. J., Inoguchi, T., and King, G. L. (1992). Diabetes 41, 1533–1539.
Bursell, S. E., Clermont, A. C., Oren, B., and King, G. L. (1995). Invest. Ophthalmol. Vis. Sci. 36, 596–607.
Chakrabarti, S., Gan, X. T., Merry, A., Karmazyn, M., and Sima, A. A. (1998). Curr. Eye Res. 17, 301–307.
Chakrabarti, S. and Sima, A. A. (1997). Diabetes Res. Clin. Pract. 37, 109–120.
Chakrabarthy, U., Hayes, R. G., Stitt, A. W., and Douglas, A. (1997). Invest. Ophthalmol. Vis. Sci. 38, 2144–2151.
Takagi, C., Bursell, S. E., Lin, Y. W., et al. (1996). Invest. Ophthalmol. Vis. Sci. 37, 2504–2518.
Mogensen, C. E., Østerby, R., and Gundersen, H. J. G. (1979). Diabetologia 17, 71–76.
Vora, J. P., Dolben, J., Dean J. D., et al. (1992). Kidney Int. 41, 829–835.
Lam, H. C., Lee, J. K., Chiang, H. T., et al. (1995). J. Cardiovasc. Pharmacol. 26(Suppl. 3), S479-S481.
De-Mattia, G., Cassone-Faldetta, M., Bellini, C., et al. (1998). Am. J. Hypertens. 11, 983–988.
Shin, S. J., Lee, Y. J., Lin, S. R., Tan, M. S., Lai, Y. H., and Tsai, J. H. (1995). Nephron 70, 486–493.
Awazu, M., Parker, R. E., Harvie, B. R., Ichikawa, I., and Kon, V. (1991). J. Cardiovasc. Pharmacol. 17(Suppl. 7), S500-S502.
Hurst, R. D., Stevanovic, Z. S., Munk, S., et al. (1995). Diabetes 44, 759–766.
Anderson, S. and Brenner, B. M. (1988). Diabetes Metab. Rev. 4, 163–177.
Lee, Y. J., Shin, S. J., and Tsai, J. H. (1994). Diabetes Care 17, 253–266.
Orisio, S., Benigni, A., Bruzzi, I., et al. (1993). Kidney Int. 43, 354–358.
Zoccali, C., Leonardis, D., Parlongo, S., Mallamaci, F., and Postorino, M. (1995). Nephrol. Dial. Transplant 10, 1320–1323.
Simonson, M. S., Wann, S., Mene, P., et al. (1989). J. Clin. Invest. 83, 708–712.
Ishimura, E., Shouji, S., Nishizawa, Y., Morii, H., and Kashgarian, M. (1991). J. Am. Soc. Nephrol. 2, 546.
Nayer, W. G. (1990). Endothelin and the kidney. In: The Endothelins. Nayer, W. G. (ed.). Springer-Verlag: Berlin.
Dyck, P. J. (1989). Neurology 39, 111–118.
Cameron, N. E., Cotter, M. A., and Low, P. A. (1991). Am. J. Physiol. 261, E1-E8.
Tuck, R. R., Schmelzer, J. D., and Low, P. A. (1984). Brain 107, 935–950.
Pugliese, G., Tilton, R. G., Speedy, A., et al. (1989). Diabetologia 32, 845–857.
Zochodne, D. W. and Ho, L. T. (1992). Can. J. Physiol. Pharmacol. 70, 651–659.
Zochodne, D. W., Ho, L. T., and Allison, J. A. (1994). J. Neurol. Sci. 127, 36–42.
Nukada, H. (1986). Diabetes 35, 1058–1061.
Nukada, H. (1992). Muscle Nerve 15, 1116–1122.
Kihara, M. and Low, P. A. (1995). Exp. Neurol. 132, 180–185.
Zochodne, D. W., Ho, L. T., and Gross, P. M. (1992). Am. J. Physiol. 263, H1806-H1810.
Zochodne, D. W., Cheng, C. and Sun, H. (1996). Diabetes 45, 627–632.
Lam, H. C., Takahashi, K., Ghatei, M. A., Warrens, A. N., Rees, A. J., and Bloom, S. R. (1991). J. Cardiovasc. Pharmacol. 17(Suppl. 7), S390-S393.
Cameron, N. E. and Cotter, M. A. (1996). J. Pharmacol. Exp. Ther. 278, 1262–1268.
Cameron, N. E., Dines, K. C., and Cotter, M. A. (1994). Diabetologia 37, 1209–1215.
Bassirat, M. and Khalil, Z. (2000). Microvasc. Res. 59, 88–98.
Stevens, E. J. and Tomlinson, D. R. (1995). Br. J. Pharmacol. 115, 373–379.
Francavilla, S., Properzi, G., Bellini, C., Marino, G., Ferri, C., and Santucci, A. (1997). J. Urol. 158, 1770–1774.
Saenz de Tejada, I., Carson, M. P., De Las Morenas, A., Goldstein, I., and Traish, A. M. (1991). Am. J. Physiol. 261, H1078-H1085.
Takahashi, K., Ghatei, M. A., Lam, H. C., O'Halloram, D. J., and Bloom, S. R. (1990). Diabetologia 33, 306–310.
Morise, T., Takeuchi, Y., Kawano, M., Koni, I., and Takeda, R. (1995). Diabetes Care 18, 87–89.
Kawamura, M., Ohgawara, H., Naruse, M., et al. (1992). Diabetes Care 15, 1396,1397.
Donatelli, M., Colletti, I., Bucalo, M. L., Russo, V., and Verga, S. (1994) Diabetes Res. 25, 159–164.
Letizia, C., Iannaccone, A., Cerci, S., et al. (1997). Horm. Metab. Res. 29, 247–251.
Laurenti, O., Vingolo, E. M., Desideri, G. B., et al. (1997). Exp. Clin. Endocrinol. Diabetes 105(Suppl. 2), 40–42.
Haak, T., Jungmann, E., Felber, A., Hillmann, U., and Usadel, K. H. (1992). Am. J. Hypertens. 5, 161–166.
Bertello, P., Veglio, F., Pinna, G., Guridi, L., Molino, P., Albano, S., and Chiandussi, L. (1994). Diabetes Care 17, 574–577.
Kamoi, K., Ishibashi, M., and Yamaji, T. (1994). Diabetes Res. Clin. Pract. 24, 125–129.
Tsunoda, K., Abe, K., Sato, T., Yokosawa, S., and Yoshinaga, K. (1991). Clin. Exp. Pharmacol. Physiol. 18, 731,732.
Hoffman, A., Grossman, E., and Keiser, H. R. (1990) Eur. J. Pharmacol. 182, 603–606.
Teuscher, A., Schnell, H., and Wilson, P. W. F. (1988). Diabetes Care 11, 246–251.
Tolins, J. P. and Raij, L. (1989). Am. J. Med. 87 (Suppl. 6A), 29S-33S.
Kasiske, B. L., Kalil, R. S. N., Ma, J. Z., Liao, M., and Keane, W. F. (1993). Ann. Intern. Med. 118, 129–138.
Marre, M., Chatellier, G., Leblanc, H., Guyene, T. T., Menard, J., and Passa, P. (1988). BMJ 297, 1092–1095.
Mathiesen, E. R., Hommel, E., Giese, J., and Parving, H. H. (1991). BMJ 303, 81–87.
Chaturvedi, N., Sjolie, A. K., Stephenson, J. M., et al. (1998). Lancet 351, 28–31.
Yoshida, H. and Nakamura, M. (1992). Life Sci. 50, 195–200.
Lam, H. C., Lee, J. K., Koh, S. J., and Chiang, H. T. (1996). Acute effect of captopril on urinary excretion of endothelin in normal Chinese subjects. In: Adrenal glands, vascular system and hypertension. Vinson G. P. and Anderson, D. C. (eds.). Journal of Endocrinology Ltd: Bristol, pp. 253–257.
Ferri, C., Laurenti, O., Bellini, C., et al. (1995). Am. J. Hypertens. 8, 40–47.
Lam, H. C., Lee, J. K., Chiang, H. T., Chuang, M. J., and Wang, M. C. (1998). J. Cardiovasc. Pharmacol. 31(Suppl. 1), S496-S500.
Fukui, M., Nakamura, T., Ebihara, I., et al. (1994). J. Lab. Clin. Med. 123, 763–768.
Hocher, B., Lun, A., Priem, F., Neumayer, H. H., and Raschack, M. (1998). J. Cardiovasc. Pharmacol. 31(Suppl. 1), S492-S495.
Coutinho, M., Gerstein, H. C., Wang, Y., and Yusuf, S. (1999). Diabetes Care 22, 233–240.
Townend, J., Doran, J., Jones, S., and Davies, M. (1994). Int. J. Cardiol. 43, 299–304.
Grenier, O., Pousset, F., Isnard, R., et al. (1996). Cardiovasc. Drugs Ther. 10, 561–565.
Galatius-Jensen, S., Wroblewski, H., Emmeluth, C., Bie, P., Haunso, S., and Kastrup, J. (1996). Cardiovasc. Res. 32, 1148–1154.
Lerman, A., Hildebrand, F. L., Aarhus, L. L., and Burnett, J. C. (1991). Circulation 83, 1804–1814.
Monge, J. C. (1998). J. Cardiovasc. Pharmacol. 32(Suppl. 2), S36-S42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lam, HC. Role of endothelin in diabetic vascular complications. Endocr 14, 277–284 (2001). https://doi.org/10.1385/ENDO:14:3:277
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:14:3:277